Hypercalcemia of malignancy - Revision history

ClaireLewis at 00:59, 29 September 2019

2019-09-29T00:59:08Z

← Older revision		Revision as of 00:59, 29 September 2019
Line 2:		Line 2:
	===Causes===		===Causes===
	*PTHrP release		*PTHrP release
	**SCC (particularly of the head and neck), breast renal, endometrial cancer		**[[squamous cell carcinoma\|SCC]] (particularly of the head and neck), breast renal, endometrial cancer
	*Local osteolysis		*Local osteolysis
	**Associated primarily with bone mets		**Associated primarily with bone mets
	**Multiple myeloma, lung, breast cancer		**[[Multiple myeloma]], lung, breast cancer
	*Production of vitamin D analogues		*Production of vitamin D analogues
	**[[Lymphoma]] (Hodgkin)		**[[Lymphoma]] (Hodgkin)
Line 18:		Line 18:

	==Evaluation==		==Evaluation==
	*~~Chem10~~		*Chemistry
	*Ionized Ca		*Ionized Ca
	*CBC		*CBC
	*LFTs (alk phos, albumin)		*[[LFTs]] (alk phos, albumin)
	*[[ECG]]		*[[ECG]]

Line 31:		Line 31:
	**Home with follow up if oncology concurs		**Home with follow up if oncology concurs
	*Ca>12		*Ca>12
	**Admit ~~ward~~		**Admit
	*[[ECG]] changes		*[[ECG]] changes
	**Admit telemetry		**Admit with telemetry

	==See Also==		==See Also==

Rossdonaldson1: Text replacement - "ECG" to "ECG"

2016-09-09T11:28:02Z

Text replacement - "*ECG" to "*ECG"

← Older revision		Revision as of 11:28, 9 September 2016
Line 22:		Line 22:
	*CBC		*CBC
	*LFTs (alk phos, albumin)		*LFTs (alk phos, albumin)
	*ECG		*[[ECG]]

	==Management==		==Management==
Line 32:		Line 32:
	*Ca>12		*Ca>12
	**Admit ward		**Admit ward
	*ECG changes		*[[ECG]] changes
	**Admit telemetry		**Admit telemetry

Neil.m.young: Text replacement - "==Diagnosis==" to "==Evaluation=="

2016-07-26T09:18:11Z

Text replacement - "==Diagnosis==" to "==Evaluation=="

← Older revision		Revision as of 09:18, 26 July 2016
Line 17:		Line 17:
	{{Oncologic emergencies DDX}}		{{Oncologic emergencies DDX}}

	==~~Diagnosis~~==		==Evaluation==
	*Chem10		*Chem10
	*Ionized Ca		*Ionized Ca

Rossdonaldson1: Text replacement - "f/u" to "follow up"

2016-07-12T23:07:21Z

Text replacement - "f/u" to "follow up"

← Older revision		Revision as of 23:07, 12 July 2016
Line 29:		Line 29:
	==Disposition==		==Disposition==
	*Ca <12		*Ca <12
	**Home with ~~f/u~~ if oncology concurs		**Home with follow up if oncology concurs
	*Ca>12		*Ca>12
	**Admit ward		**Admit ward

Neil.m.young: Text replacement - "==Treatment==" to "==Management=="

2016-07-08T02:47:28Z

Text replacement - "==Treatment==" to "==Management=="

← Older revision		Revision as of 02:47, 8 July 2016
Line 24:		Line 24:
	*ECG		*ECG

	==~~Treatment~~==		==Management==
	{{Hypercalcemia treatment}}		{{Hypercalcemia treatment}}

Rossdonaldson1: /* Clinical Features */

2015-12-16T19:07:10Z

Clinical Features

← Older revision		Revision as of 19:07, 16 December 2015
Line 10:		Line 10:

	==Clinical Features==		==Clinical Features==
	*See [[Hypercalcemia]]		{{Hypercalcemia clinical features}}

	==Differential Diagnosis==		==Differential Diagnosis==

Rossdonaldson1: /* References */

2015-12-16T19:05:56Z

References

← Older revision		Revision as of 19:05, 16 December 2015
Line 39:		Line 39:

	==References==		==References==
			<references/>
	[[Category:FEN]]		[[Category:FEN]]
	[[Category:Heme/Onc]]		[[Category:Heme/Onc]]

Rossdonaldson1: /* Treatment */

2015-12-16T18:57:45Z

Treatment

← Older revision		Revision as of 18:57, 16 December 2015
Line 25:		Line 25:

	==Treatment==		==Treatment==
	*See [[Hypercalcemia]]		{{Hypercalcemia treatment}}

	==Disposition==		==Disposition==

Rossdonaldson1 at 04:27, 25 June 2015

2015-06-25T04:27:06Z

← Older revision		Revision as of 04:27, 25 June 2015
Line 1:		Line 1:
	==Background==		==Background==
	===Causes===		===Causes===
	#PTHrP release		*PTHrP release
	##SCC (particularly of the head and neck), breast renal, endometrial cancer		**SCC (particularly of the head and neck), breast renal, endometrial cancer
	#Local osteolysis		*Local osteolysis
	##Associated primarily with bone mets		**Associated primarily with bone mets
	##Multiple myeloma, lung, breast cancer		**Multiple myeloma, lung, breast cancer
	#Production of vitamin D analogues		*Production of vitamin D analogues
	##[[Lymphoma]] (Hodgkin)		**[[Lymphoma]] (Hodgkin)

	==Clinical Features==		==Clinical Features==
	#See [[Hypercalcemia]]		*See [[Hypercalcemia]]

	==Differential Diagnosis==		==Differential Diagnosis==
Line 18:		Line 18:

	==Diagnosis==		==Diagnosis==
	#Chem10		*Chem10
	#Ionized Ca		*Ionized Ca
	#CBC		*CBC
	#LFTs (alk phos, albumin)		*LFTs (alk phos, albumin)
	#ECG		*ECG

	==Treatment==		==Treatment==
	#See [[Hypercalcemia]]		*See [[Hypercalcemia]]

	==Disposition==		==Disposition==
	#Ca <12		*Ca <12
	##Home with f/u if oncology concurs		**Home with f/u if oncology concurs
	#Ca>12		*Ca>12
	##Admit ward		**Admit ward
	#ECG changes		*ECG changes
	##Admit telemetry		**Admit telemetry

	==See Also==		==See Also==

Rossdonaldson1: /* Background */

2015-06-25T04:26:35Z

Background

← Older revision		Revision as of 04:26, 25 June 2015
Line 1:		Line 1:
	==Background==		==Background==
	#Causes:		===Causes===
	##PTHrP release		#PTHrP release
	###SCC (particularly of the head and neck), breast renal, endometrial cancer		##SCC (particularly of the head and neck), breast renal, endometrial cancer
	##Local osteolysis		#Local osteolysis
	###Associated primarily with bone mets		##Associated primarily with bone mets
	###Multiple myeloma, lung, breast cancer		##Multiple myeloma, lung, breast cancer
	##Production of vitamin D analogues		#Production of vitamin D analogues
	###Lymphoma (Hodgkin)		##[[Lymphoma]] (Hodgkin)

	==Clinical Features==		==Clinical Features==